Table 2 Procedural characteristics of the Patent group and the Occluded group at graft-level
Items | Patent (910) | Occluded (45) | P |
|---|---|---|---|
On-pump | 406 (44.62) | 23 (51.11) | 0.444 |
SVG harvest technique | 0.072 | ||
Endoscopic | 103 (11.32) | 11 (24.44) | |
Open | 443 (48.68) | 23 (51.11) | |
Proximal anastomosis technique | 0.079 | ||
PAC | 151 (16.59) | 7 (15.56) | |
Proximal anastomosis device | 282 (30.99) | 20 (44.44) | |
SAC | 115 (12.64) | 8 (17.78) | |
No-touch | 362 (39.78) | 10 (22.22) | |
Grafting strategy | |||
In situ IMAs | 354 (38.90) | 9 (20.00) | 0.000 |
AO-SVG | 530 (58.24) | 30 (66.67) | |
Composited | 19 (2.09) | 6 (13.33) | |
Free IMAs | 7 (0.77) | 0 (0.00) | |
IABP | 0.383 | ||
No-use | 820 (90.11) | 38 (84.44) | |
Pre-operation | 42 (4.62) | 4 (8.89) | |
Intra-operation | 30 (3.30) | 2 (4.44) | |
Post-operation | 13 (1.43) | 0 (0.00) | |
Number of vessel conduits | 3.0 (3.0–4.0) | 4.0 (3.0–4.0) | 0.198 |
PI | 2.4 (1.8–3.2) | 3.4 (2.3–5.1) | 0.000 |
MGF | 26.0 (18.0–39.0) | 23.0 (14.0–39.0) | 0.152 |
DF | 69.0 (63.0–76.0) | 63.0 (51.8–74.3) | 0.007 |
Bleeding | 500 (350–800) | 500 (300–900) | 0.812 |
Postoperative TNI max | 1.8 (0.8–4.4) | 3.0 (1.4–4.4) | 0.022 |
Postoperative CK-MB max | 12.8 (6.2–23.2) | 16.5 (9.7–28.9) | 0.032 |
Mechanical ventilation time | 11.0 (8.0–18.0) | 11.5 (8.0–17.0) | 0.525 |
Operation time | 270.0 (240.0–310.0) | 265.0 (240.0–307.5) | 0.914 |
Antiplatelet strategy | 0.022 | ||
Aspirin | 427 (46.92) | 30 (66.67) | |
Clopidogrel | 33 (3.63) | 2 (4.44) | |
Dual-antiplatelet | 443 (48.68) | 12 (26.67) | |
New POAF (n, %) | 232 (25.49) | 17 (37.78) | 0.077 |
CRRT (n, %) | 13 (1.43) | 1 (2.22) | 0.487 |